Dr Reddy's Laboratories

quarterly
yearly
ParticularsDec '21Mar '22Jun '22Sep '22Dec '22
Revenue5,3385,4755,2336,3326,790
Expenses4,4175,3104,5814,7425,175
EBITDA921.50164.70651.601,5901,615
EBIT627.30-128.30349.801,2811,291
Profit Before Tax974.20258.901,4681,6141,638
Net Profit709.3097.001,1891,1141,244
Financial Ratios
Operating Profit Margin17.26%3.01%12.45%25.11%23.78%
Net Profit Margin13.29%1.77%22.72%17.60%18.32%
Earning Per Share (Diluted)42.8634.7871.4867.0875.37
Dividends Per ShareNA30.00NANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.8.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI